- Home
- SYBX vs CAPT Comparison
SYBX vs CAPT Comparison
Compare SYBX & CAPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYBX
- CAPT
- Stock Information
- Founded
- SYBX N/A
- CAPT 2005
- Country
- SYBX United States
- CAPT South Korea
- Employees
- SYBX N/A
- CAPT N/A
- Industry
- SYBX Biotechnology: Pharmaceutical Preparations
- CAPT Blank Checks
- Sector
- SYBX Health Care
- CAPT Finance
- Exchange
- SYBX Nasdaq
- CAPT Nasdaq
- Market Cap
- SYBX 13.6M
- CAPT 16.0M
- IPO Year
- SYBX N/A
- CAPT N/A
- Fundamental
- Price
- SYBX $1.07
- CAPT $0.46
- Analyst Decision
- SYBX
- CAPT
- Analyst Count
- SYBX 0
- CAPT 0
- Target Price
- SYBX N/A
- CAPT N/A
- AVG Volume (30 Days)
- SYBX 11.1K
- CAPT 171.4K
- Earning Date
- SYBX 05-20-2025
- CAPT 01-01-0001
- Dividend Yield
- SYBX N/A
- CAPT N/A
- EPS Growth
- SYBX N/A
- CAPT N/A
- EPS
- SYBX 0.21
- CAPT N/A
- Revenue
- SYBX N/A
- CAPT $17,389,944.00
- Revenue This Year
- SYBX N/A
- CAPT N/A
- Revenue Next Year
- SYBX N/A
- CAPT N/A
- P/E Ratio
- SYBX $5.25
- CAPT N/A
- Revenue Growth
- SYBX N/A
- CAPT 84.70
- 52 Week Low
- SYBX $0.90
- CAPT $0.37
- 52 Week High
- SYBX $1.91
- CAPT $5.72
- Technical
- Relative Strength Index (RSI)
- SYBX 45.73
- CAPT 40.39
- Support Level
- SYBX $1.00
- CAPT $0.44
- Resistance Level
- SYBX $1.19
- CAPT $0.51
- Average True Range (ATR)
- SYBX 0.09
- CAPT 0.02
- MACD
- SYBX 0.00
- CAPT -0.00
- Stochastic Oscillator
- SYBX 55.00
- CAPT 29.40
About SYBX Synlogic Inc.
Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.
About CAPT Captivision Inc.
Captivision Inc Formerly Glaam Co Ltd is engaged in manufacturing, installing, and selling LED display G-Glass. G-Glass is an integrated ICT product that has the basic characteristics of transparent glass but can display media images at the same time. It implements media images through the glass surface while preserving the features of clear and transparent glass. G-Glass is the world's first IT building material that can be applied to various places where glass is used.